Hyderabad: The Telangana Drugs Control Administration (DCA) has issued a spurious drug alert and stop-use notice of all certain drugs claimed on the label as manufactured by 'Meg Lifesciences', Palli Gaon, Distt. Sirmour of Himachal Pradesh, that are being circulated in the market.
Upon investigation, it has been confirmed that ‘Meg Lifesciences is a fictitious or non-existent company, DCA Director General VB Kamalasan Reddy said in a release here.
These drugs have been found to be falsified medicines, manufactured by anti-social elements, containing no active ingredient (‘Nil’ medicine).
They have been found to contain chalk powder and starch, posing significant health risks to
consumers.
In light of these grave findings, the DCA has issued a Spurious Drug Alert and Stop Use Notice for all drugs claiming to be manufactured by Meg Lifesciences.
Consumers and healthcare professionals are informed to STOP USE immediately—to discontinue the use of any drugs claiming to be manufactured by Meg Lifesciences.
Retailers and wholesalers are directed to STOP the sale and distribution of any drugs bearing the label ‘Meg Lifesciences’ and to inform the area Drugs Inspector immediately.
The DCA officials are taking stringent measures to curb the menace of spurious drugs and has seized stocks claimed to be manufactured by Meg Lifesciences worth Rs. 33.35 lakhs during the recent raids.
Cases have been registered against several offenders involved in this spurious drug racket.
DCA is actively working to ensure the removal of these spurious drugs from the market.
DCA urged the public to remain vigilant and report any information regarding the distribution or sale of drugs from this purported manufacturer, ‘Meg Lifesciences, to the nearest DCA office or to the local Drugs Inspector or DCA Assistant Director, whose contact number and address of the office are available on the DCA portal, https://dca.telangana.gov.in/, under the ‘Key Contacts’section,n or to the DCA Toll-Free Number 1800-599-6969, which is operational on all working days, the release added.
